NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Like I've told you all here many times, there are plenty of GBM trials where the government won't need to pay for them. Right or wrong, mRNA is the government's darling. Watch and learn.

>>Last year, the Government signed an agreement with BioNTech to provide up to 10,000 patients with precision cancer immunotherapies by 2030.

BioNTech has already begun conducting clinical trials in the UK, and the NHS launch pad is helping to accelerate the identification of eligible patients for those trials in England.